Intravenous immunoglobulin treatment in multifocal motor neuropathy.
BACKGROUND
Multifocal motor neuropathy (MMN) is characterized by asymmetric weakness of limbs and the electrophysiological finding of conduction block in motor nerves. Conduction block is the inability of nerves to propagate action potentials and is probably caused by immune-mediated dysfunction of the axon at the nodes of Ranvier or the myelin sheath. MMN immune pathogenesis has not been elucidated.


RESULTS
In approximately 50% of all patients, IgM antibodies that bind to the glycolipid GM1, which is abundantly expressed in peripheral motor nerves, can be detected. A recent study showed an association with HLA-DRB1*15, and virtually all patients respond to treatment with intravenous immunoglobulin (IVIG) in at least the early stages of the disease.


CONCLUSIONS
This review aims at providing a concise overview of what is known about MMN pathogenesis, and how the beneficial effect of IVIG might be explained.
van der Pol
W-Ludo
WL
Rudolf Magnus Institute of Neuroscience, Department of Neurology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, the Netherlands.
Cats
Elisabeth A
EA
van den Berg
Leonard H
LH
D000328:Adult; D000368:Aged; D001323:Autoantibodies / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D020274:Autoimmune Diseases of the Nervous System / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D005260:Female; D005544:Forecasting; D005677:G(M1) Ganglioside / Q000276:immunology; D020022:Genetic Predisposition to Disease; D006684:HLA-DR Antigens / Q000235:genetics / Q000276:immunology; D059811:HLA-DRB1 Chains; D006801:Humans; D007075:Immunoglobulin M / Q000276:immunology; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016472:Motor Neuron Disease / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D009431:Neural Conduction; D010525:Peripheral Nerves / Q000473:pathology; D055815:Young Adult
D001323:Autoantibodies; D001324:Autoantigens; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; C507799:HLA-DRB1*15 antigen; D007075:Immunoglobulin M; D016756:Immunoglobulins, Intravenous; D005677:G(M1) Ganglioside
J Neuropathol Exp Neurol. 2004 Feb;63(2):129-37
14989599
J Neuroimmunol. 2007 May;186(1-2):161-3
17428545
Brain. 2008 May;131(Pt 5):1197-208
18184663
Ann Neurol. 1988 Jul;24(1):73-8
2843079
Brain. 2005 Jul;128(Pt 7):1642-8
15888541
J Neuroimmunol. 2001 Apr 2;115(1-2):4-18
11282149
Muscle Nerve. 1997 Jan;20(1):15-21
8995578
Eur Neurol. 1998;39(2):103-10
9520071
Brain. 2002 Dec;125(Pt 12):2591-625
12429589
J Neurosci. 2007 Apr 11;27(15):3956-67
17428969
Brain. 2002 Nov;125(Pt 11):2481-90
12390974
Neurology. 2002 Dec 24;59(12 Suppl 6):S13-21
12499466
Lancet Neurol. 2005 May;4(5):309-19
15847844
J Neuroimmunol. 2008 Dec 15;205(1-2):101-4
18973956
Neurology. 2002 Jul 23;59(2):282-4
12136073
J Neurol Neurosurg Psychiatry. 2006 Jun;77(6):743-7
16705197
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4788-92
19261857
J Peripher Nerv Syst. 2006 Mar;11(1):67-71
16519784
Brain. 2002 Mar;125(Pt 3):664-75
11872621
Neurology. 2010 Mar 9;74(10):828-32
20211906